ARTICLE | Company News
Arakis and Vectura to develop COPD therapy
November 30, 2000 8:00 AM UTC
Arakis ( Cambridge, U.K.) and Vectura (Bath, U.K.) will develop Arakis' AD 237 long acting inhaled bronchodilator formulation to treat chronic obstructive pulmonary disease (COPD). Vectura will formul...